`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`
`BIOCON BIOLOGICS INC.,
`Petitioner,
`
`v.
`REGENERON PHARMACEUTICALS, INC.,
`Patent Owner.
`
`
`IPR2024-00298
`Patent 11,253,572 B2
`
`
`
`Petitioner’s Amended Mandatory Notices
`
`
`
`
`
`
`
`
`
`
`
`
`Biocon Biologics Inc. (“Petitioner”) submits the following amended
`
`mandatory notices to identify additional related matters and to update back-up
`
`counsel information.
`
` REAL PARTIES-IN-INTEREST (37 C.F.R. § 42.8(b)(1)).
`Petitioner Biocon Biologics Inc., Biocon Limited, Biocon Biologics Limited,
`
`Biocon Biologics UK Limited, and Biosimilar Collaborations Ireland Limited are
`
`real parties-in-interest (“RPIs”) to the current Petition. Biocon Biologics Limited is
`
`a subsidiary of Biocon Limited, a publicly traded company. Biocon Biologics UK
`
`Limited is a wholly owned subsidiary of Biocon Biologics Limited, and Biosimilar
`
`Collaborations Ireland Limited and Biocon Biologics Inc. are wholly owned
`
`subsidiaries of Biocon Biologics UK Limited.
`
`Further RPIs include Mylan Pharmaceuticals Inc. (“Mylan”) and Johnson &
`
`Johnson. Viatris Inc. and Mylan Inc. are parent companies of Mylan Pharmaceuticals
`
`Inc. Accordingly, Viatris Inc., Mylan Inc., and Mylan Pharmaceuticals Inc. are
`
`identified as RPIs to the current Petition. Momenta Pharmaceuticals, Inc. and
`
`Janssen Research & Development LLC are wholly-owned subsidiaries of Johnson
`
`& Johnson, a publicly held company. Momenta Pharmaceuticals, Inc., Janssen
`
`Research & Development LLC, and Johnson & Johnson are also RPIs to the current
`
`Petition.
`
`No other parties exercised or could have exercised control over this Petition;
`
`
`
`no other parties funded, directed, and controlled this Petition. See Trial Practice
`
`Guide, 15-16 (November 2019).
`
` RELATED MATTERS (37 C.F.R. § 42.8(b)(2)) (AMENDED).
`Petitioner identifies Samsung Bioepis Co., Ltd. v. Regeneron Pharms., Inc.,
`
`IPR2023-00884 (P.T.A.B.), Mylan Pharms. Inc. v. Regeneron Pharms., Inc., No.
`
`IPR2022-01225 (P.T.A.B.), and Mylan Pharms. Inc. v. Regeneron Pharms., Inc.,
`
`No. IPR2022-01226 (P.T.A.B.). Petitioner also identifies Mylan Pharms. Inc. v.
`
`Regeneron Pharms., Inc., No. IPR2021-00880 (P.T.A.B.), Mylan Pharms. Inc. v.
`
`Regeneron Pharms., Inc., No. IPR2021-00881 (P.T.A.B.), Mylan Pharms. Inc. v.
`
`Regeneron Pharms., Inc., No. IPR2023-00099 (P.T.A.B.), Biocon Biologics Inc. v.
`
`Regeneron Pharms., Inc., No. IPR2024-00201 (P.T.A.B.), Regeneron Pharms., Inc.
`
`v. Mylan Pharms. Inc., No. 2023-1395 (Fed. Cir.), Regeneron Pharms., Inc. v. Mylan
`
`Pharms. Inc., No. 2023-1396 (Fed. Cir.), Regeneron Pharms., Inc. v. Mylan Pharms.
`
`Inc., 1:22-cv-00061-TSK (N.D.W. Va.); Regeneron Pharms., Inc. v. Celltrion, Inc.,
`
`1:23-cv-00089-TSK (N.D.W. Va.); Regeneron Pharms., Inc. v. Samsung Bioepis,
`
`Co. Ltd., 1:23-cv-00094-TSK (N.D.W. Va.); Regeneron Pharms., Inc. v. Formycon
`
`AG, 1:23-cv-00097-TSK (N.D.W. Va.); Regeneron Pharms., Inc. v. Samsung
`
`Bioepis, Co. Ltd., 1:23-cv-00106-TSK (N.D.W. Va.); and Regeneron Pharms., Inc.
`
`v. Amgen Inc., 2:24-cv-00264-JAK-E (C.D. Cal.). To the best of Petitioner’s
`
`knowledge, the following are additional judicial or administrative matters that would
`
`2
`
`
`
`affect, or be affected by, a decision in this proceeding: Cel/trion, Inc. v. Regeneron
`
`Pharms.,
`
`Inc., No.
`
`IPR2024-00260 (P.T.A.B.), Apotex Inc.
`
`v. Regeneron
`
`Pharmaceuticals, Inc., No. IPR2022-01524 (P.T.A.B.), Samsung Bioepis Co., Ltd.
`
`v. Regeneron Pharms., Inc., 1PR2023-00442 (P.T.A.B.), Samsung Bioepis Co. Ltd.
`
`v. Regeneron Pharms., Inc., No. IPR2023-00739 (P.T.A.B.), United States v.
`
`Regeneron Pharms.,
`
`Inc., No. 1:20-cv-11217-FDS (D. Mass.), and Horizon
`
`Healthcare Servs., Inc. v. Regeneron Pharms., Inc., No. 1:22-cv-10493-FDS (D.
`
`Mass.).
`
`U:S. Patent Nos. 9,254,338 B2; 9,669,069 B2: 10,857,205 B2; 10,828,345 B2:
`
`10,130,681 B2; 10,888,601 B2; 11,559,564 B2; 11,707,506 B2; and 11,730,794 B2:
`
`and U.S. Patent Application Nos. 17/072,417; 17/112,063; and 18/496,472 each
`
`claim the benefit of the °572 patent’s purported priority date.
`
`C.
`
`LEAD AND BACK-UP COUNSEL AND SERVICE INFORMATION (37
`C.F.R. § 42.8(b)(3)-(4)).
`
`Petitioner identifies its lead and backup counsel below.
`
`
`
`Paul J. Molino (Reg. No. 45,350)
`William A. Rakoczy
`paul@rmmslegal.com
`(pro hac vice to be filed)
`
`wrakoczy@rmmmslegal.com
`
`
`
`
`
`Deanne M. Mazzochi (Reg. No. 50,158)
`dmazzochi@rmmslegal.com
`
`Heinz J. Salmen
`
`
`
`Postal and Hand Delivery Address
`Rakoczy Molino Mazzochi Siwik LLP
`6 West HubbardStreet
`Chicago, IL 60654
`Telephone: (312) 222-6300
`
`
`
`
`
`
`Facsimile: (312) 843-6260
`
`Petitioner consents to email service at:
`MYL_REG_IPR@rmmslegal.com
`
`
`(pro hac vice to be filed)
`hsalmen@rmmslegal.com
`
`Eric R. Hunt
`(pro hac vice to be filed)
`ehunt@rmmslegal.com
`
`Neil B. McLaughlin (Reg. No. 70,810)
`nmclaughlin@rmmslegal.com
`
`Lauren M. Lesko
`(pro hac vice to be filed)
`llesko@rmmslegal.com
`
`L. Scott Beall (Reg. No. 52,601)
`sbeall@rmmslegal.com
`
`Thomas H. Ehrich (Reg. No. 67,122)
`tehrich@rmmslegal.com
`
`Steven J. Birkos (Reg. No. 65,300)
`sbirkos@rmmslegal.com
`
`Jake R. Ritthamel
`(pro hac vice to be filed)
`jritthamel@rmmslegal.com
`
`Postal and Hand Delivery Address
`Rakoczy Molino Mazzochi Siwik LLP
`6 West Hubbard Street
`Chicago, IL 60654
`Telephone: (312) 527-2157
`Facsimile: (312) 843-6260
`
`
`Please direct all correspondence to lead and back-up counsel at the contact
`
`information above.
`
` Petitioner also consents
`
`to service by email at:
`
`MYL_REG_IPR@rmmslegal.com.
`
`4
`
`
`
`Dated: January 18, 2024
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Respectfully Submitted,
`
`RAKOCZY MOLINO MAZZOCHI SIWIK LLP
`
` /Paul J. Molino/
`Paul J. Molino
`Registration No. 45,350
`6 West Hubbard Street
`Chicago, IL 60654
`Telephone:
`(312) 222-6300
`Facsimile:
`(312) 843-6260
`paul@rmmslegal.com
`
`
`Counsel for Petitioner
`
`5
`
`
`
`CERTIFICATE OF SERVICE
`
`The undersigned hereby certifies that a true and correct copy of the foregoing
`
`Petitioner’s Amended Mandatory Notices was served on January 18, 2024, via
`
`electronic mail, to the following counsel of record for Patent Owner:
`
`
`
`
`
`Adam R. Brausa (Reg. No. 60,287)
`Rebecca Weires (Reg. No. 77,895)
`Duralyn J. Durie (pro hac vice to be
`filed)
`Morrison & Foerster LLP
`425 Market Street
`San Francisco, CA 94105
`Tel: 415.268,6053
`Tel: 415.268.6028
`Tel: 415.268.6055
`abrausa@mofo.com
`rweires@mofo.com
`ddurie@mofo.com
`
`
`Dated: January 18, 2024
`
`
`
`
`Kira A. Davis (pro hac vice to be filed)
`Morrison & Foerster LLP
`707 Wilshire Blvd., Suite 6000
`Los Angeles, CA 90017
`Tel: 213.892,5654
`kiradavis@mofo.com
`
`Respectfully Submitted,
`RAKOCZY MOLINO MAZZOCHI SIWIK LLP
`/Paul J. Molino/
`
`6
`
`
Accessing this document will incur an additional charge of $.
After purchase, you can access this document again without charge.
Accept $ Charge
Still Working On It
This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.
Give it another minute or two to complete, and then try the refresh button.
A few More Minutes ... Still Working
It can take up to 5 minutes for us to download a document if the court servers are running slowly.
Thank you for your continued patience.
This document could not be displayed.
We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.
Your account does not support viewing this document.
You need a Paid Account to view this document. Click here to change your account type.
Your account does not support viewing this document.
Set your membership
status to view this document.
With a Docket Alarm membership, you'll
get a whole lot more, including:
- Up-to-date information for this case.
- Email alerts whenever there is an update.
- Full text search for other cases.
- Get email alerts whenever a new case matches your search.
One Moment Please
The filing “” is large (MB) and is being downloaded.
Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.
Your document is on its way!
If you do not receive the document in five minutes, contact support at support@docketalarm.com.
Sealed Document
We are unable to display this document, it may be under a court ordered seal.
If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.
Access Government Site
